Cigna Investments’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-940
Closed -$207K 465
2022
Q4
$207K Buy
+940
New +$172K 0.04% 428
2022
Q1
Sell
-787
Closed -$213K 672
2021
Q4
$213K Sell
787
-48
-6% -$16.2K 0.02% 616
2021
Q3
$303K Hold
835
0.02% 556
2021
Q2
$287K Hold
835
0.02% 593
2021
Q1
$291K Hold
835
0.02% 605
2020
Q4
$216K Buy
+835
New +$230K 0.02% 668

Other funds holding ONC

Cigna Investments's ONC Position: Q1 2023 in Review

Cigna Investments sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 940 shares — an estimated $207K sold.

Cigna Investments first reported a position in ONC in Q4 2020 and held it in 6 quarters. The position peaked at $303K in Q3 2021. 220 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

  • Cigna Investments reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
  • Cigna Investments sold 940 BeOne Medicines Ltd shares in Q1 2023, an estimated $207K.
  • Cigna Investments first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 6 quarters.
  • Cigna Investments's BeOne Medicines Ltd position peaked at $303K in Q3 2021.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on Cigna Investments's 13F filing for Q1 2023, filed 11 May 2023.